Brent Plummer, APRN
Psychiatric/Mental Health · Crestview Hills, KYNPI 1083107056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 314 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 33.7% of the total. Among psychiatric/mental health clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $31.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- Axsome Therapeutics, Inc.$1K
- Lundbeck LLC$898
- plus $1K from 11 others
What the payments were for
- Food & beverage$9,989100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $3,362 |
| Teva Pharmaceuticals USA, Inc. | 44 | $1,316 |
| Otsuka America Pharmaceutical, Inc. | 43 | $1,097 |
| Alkermes, Inc. | 38 | $1,012 |
| Axsome Therapeutics, Inc. | 17 | $1,001 |
| Lundbeck LLC | 60 | $898 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $566 |
| Luye Pharma (USA) Ltd. | 5 | $205 |
| Idorsia Pharmaceuticals US Inc | 3 | $131 |
| Corium, LLC | 1 | $119 |
| Noven Therapeutics, LLC | 5 | $102 |
| Ironshore Pharmaceuticals Inc. | 1 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Johnson & Johnson | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Bioxcel Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$1,928
- LYBALVI$1,332
- Auvelity$682
- CAPLYTA$362
- Austedo XR$355
- AUSTEDO$224
- ABILIFY MAINTENA$217
- ERZOFRI EXTENDED-RELEASE$129
- QUVIVIQ$123
- Azstarys$119
- ABILIFY ASIMTUFII$116
- REXULTI$106
How this compares
$9,989 in reported general payments places this provider in the 95th percentile of 946 psychiatric/mental health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 15 | $583 |
| Buspirone Hcl | 22 | $308 |
| Trazodone Hcl | 39 | $297 |
| Hydroxyzine Pamoate | 14 | $294 |
| Prazosin Hcl | 19 | $231 |
| Quetiapine Fumarate | 12 | $197 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Crestview Hills
- Jennifer SampangCrestview Hills$322K
- Molly LutzCrestview Hills$71K
- Sithandiwe MamutseCrestview Hills$13K
- Amerika HullCrestview Hills$8K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.